The Purdue Cancer Center is a basic cancer research center that organizes and maintains a multidisciplinary program for experimental cancer research. It focuses the diverse basic research strengths of Purdue University on elucidation of the molecular events involved in cell transformation as the basis for new approaches for the prevention, diagnosis and therapy of cancer. These strengths include expertise in: isolation and synthesis of new anticancer drugs; mechanisms by which DNA alterations lead to cancer; molecular signaling, especially the role of tyrosine phosphorylation; utilization of protein molecular structural determinations to develop new therapeutic approaches and many other areas of expertise all of which are focused together on cancer research through the three program areas. The Purdue Cancer Center organizes and expands existing programs in cancer research at Purdue University, stimulates new research in selected areas, contributes to advanced training in cancer research, and develops interactions among Purdue cancer researchers and cancer researchers at other institutions. The Cancer Center conducts research in three major program areas: Experimental Therapeutics and Diagnostics, Structural Biology, and Cell Growth and Differentiation. All areas are supported by individual and group research grants. To facilitate these research programs the Cancer Center provides shared resources through the Cancer Center Support Grant that include: Analytical Cytology, DNA Analysis, Drug Development, Macromolecular Crystallography, Mass Spectrometry, Nuclear Magnetic Resonance, and Transgenic Mouse facilities. In addition, the Cancer Center Support Grant provides developmental new investigator funds to recruit faculty to enhance the cancer research focus of the program areas and provides aid in planning and evaluation. This application requests continued support for the administration and organization of the Center, planning and evaluation, shared resources, and the recruitment of new cancer research faculty. The Cancer Center Support Grant has already resulted in the development of a broad basic research program directed to understanding the causes of cancer, the growth of cancer cells, and the development of new approaches to the treatment of cancer. The requested funds will allow the Purdue Cancer Center to continue to focus the diverse basic research strengths of Purdue University on solutions to the cancer problem.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA023168-21
Application #
2899982
Study Section
Subcommittee G - Education (NCI)
Program Officer
Ptak, Krzysztof
Project Start
1994-06-21
Project End
2003-06-30
Budget Start
1999-08-06
Budget End
2000-06-30
Support Year
21
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Purdue University
Department
Type
Organized Research Units
DUNS #
072051394
City
West Lafayette
State
IN
Country
United States
Zip Code
47907
Chambers, Andrea M; Wang, Jiao; Lupo, Kyle B et al. (2018) Adenosinergic Signaling Alters Natural Killer Cell Functional Responses. Front Immunol 9:2533
Norvil, Allison B; Petell, Christopher J; Alabdi, Lama et al. (2018) Dnmt3b Methylates DNA by a Noncooperative Mechanism, and Its Activity Is Unaffected by Manipulations at the Predicted Dimer Interface. Biochemistry 57:4312-4324
Wu, Heng; Post, Carol Beth (2018) Protein Conformational Transitions from All-Atom Adaptively Biased Path Optimization. J Chem Theory Comput 14:5372-5382
Serratore, Nina D; Baker, Kortany M; Macadlo, Lauren A et al. (2018) A Novel Sterol-Signaling Pathway Governs Azole Antifungal Drug Resistance and Hypoxic Gene Repression in Saccharomyces cerevisiae. Genetics 208:1037-1055
Liu, Wenting; Zhong, Yi-Fang; Liu, Liu-Yi et al. (2018) Solution structures of multiple G-quadruplex complexes induced by a platinum(II)-based tripod reveal dynamic binding. Nat Commun 9:3496
Denton, Kyle E; Wang, Sijie; Gignac, Michael C et al. (2018) Robustness of In Vitro Selection Assays of DNA-Encoded Peptidomimetic Ligands to CBX7 and CBX8. SLAS Discov 23:417-428
Kong, Yifan; Cheng, Lijun; Mao, Fengyi et al. (2018) Inhibition of cholesterol biosynthesis overcomes enzalutamide resistance in castration-resistant prostate cancer (CRPC). J Biol Chem 293:14328-14341
Filley, Anna; Henriquez, Mario; Bhowmik, Tanmoy et al. (2018) Immunologic and gene expression profiles of spontaneous canine oligodendrogliomas. J Neurooncol 137:469-479
Jakubison, Brad L; Schweickert, Patrick G; Moser, Sarah E et al. (2018) Induced PTF1a expression in pancreatic ductal adenocarcinoma cells activates acinar gene networks, reduces tumorigenic properties, and sensitizes cells to gemcitabine treatment. Mol Oncol 12:1104-1124
Ali, Remah; Brown, Wells; Purdy, Stephen Connor et al. (2018) Biased signaling downstream of epidermal growth factor receptor regulates proliferative versus apoptotic response to ligand. Cell Death Dis 9:976

Showing the most recent 10 out of 436 publications